Zhihang Zheng

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial.

Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial.

Journal: Infectious diseases and therapy

Published: August 24, 2025

Predictive survival modelings for HIV-related cryptococcosis: comparing machine learning approaches.

Predictive survival modelings for HIV-related cryptococcosis: comparing machine learning approaches.

Journal: Frontiers in cellular and infection microbiology

Published: December 10, 2024

Mitochondrial fusion reduces T cell susceptibility to HIV infection through citrate modulation.

Mitochondrial fusion reduces T cell susceptibility to HIV infection through citrate modulation.

Journal: Journal of leukocyte biology

Published: July 10, 2024

Correction: Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.

Correction: Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.

Journal: Infection

Published: May 17, 2024

Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a "shock and kill" strategy for ART-free virological control: a phase II single-arm study.

Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a "shock and kill" strategy for ART-free virological control: a phase II single-arm study.

Journal: Signal transduction and targeted therapy

Published: December 08, 2023

Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.

Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.

Journal: Infection

Published: November 16, 2023

Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.

Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.

Journal: Archives of osteoporosis

Published: September 27, 2023

Antiretroviral therapy-naïve people living with HIV tend to have more severe symptoms of COVID-19.

Antiretroviral therapy-naïve people living with HIV tend to have more severe symptoms of COVID-19.

Journal: Chinese medical journal

Published: August 02, 2023

Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+ T cell epitopes identified through comprehensive epitope mapping in Zika virus infected mice.

Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+ T cell epitopes identified through comprehensive epitope mapping in Zika virus infected mice.

Journal: Vaccine

Published: February 21, 2021

Correction to: Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from A Single Clinical Viral Isolate.

Correction to: Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from A Single Clinical Viral Isolate.

Journal: Virologica Sinica

Published: September 30, 2020

Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from a Single Clinical Viral Isolate.

Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from a Single Clinical Viral Isolate.

Journal: Virologica Sinica

Published: November 09, 2019

Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade.

Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade.

Journal: Frontiers in microbiology

Published: September 28, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026